insights_auto
Why is MSB down 2.76%?
Dive Deeperchevron_right
MSB:ASX
Mesoblast Ltd
A$1.94
arrow_downward
-2.76%(-0.055) 1D
Oct 8, 2:40:48 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MSB...
Open
A$1.99
High
A$2.04
Low
A$1.92
Mkt. cap
2.59B
Avg. vol.
2.55M
Volume
2.35M
52-wk high
A$3.31
52-wk low
A$1.88
EPS
-A$0.06
Shares outstanding
1.30B
No. of employees
108
Open
A$1.99
High
A$2.04
Low
A$1.92
Mkt. cap
2.59B
Avg. vol.
2.55M
Volume
2.35M
52-wk high
A$3.31
52-wk low
A$1.88
EPS
-A$0.06
Shares outstanding
1.30B
No. of employees
108
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
Mesoblast wins FDA assay approval: what it means for Mesoblast stock
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd